KDR and neoplasm: It also contributes to tumor angiogenesis by acting as a co‐receptor with VEGFR as a recent study demonstrated that anti‐NRP1 monoclonal antibody (MNRP1685A) inhibited the VEGF pathway in solid tumors.35